Theravance (THRX)

Theravance's (THRX) CEO Michael Aguiar on Q3 2015 Results - Earnings Call Transcript
Oct. 28, 2015 | Source: Seeking Alpha

Theravance (THRX) Q3 2015 Results - Earnings Call Webcast
Oct. 28, 2015 | Source: Seeking Alpha

Theravance's (THRX) CEO Michael Aguiar on Q2 2015 Results - Earnings Call Transcript
July 29, 2015 | Source: Seeking Alpha

Theravance (THRX) Q1 2015 Results - Earnings Call Webcast
May 6, 2015 | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q1 2015 Results - Earnings Call Transcript
May 6, 2015 | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q4 2014 Results - Earnings Call Transcript
Feb. 18, 2015 | Source: Seeking Alpha

Theravance (THRX) Q4 2014 Results - Earnings Call Webcast
Feb. 18, 2015 | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Credit Suisse Healthcare Conference - Call Transcript
Nov. 13, 2014 | Source: Seeking Alpha

Theravance (THRX) Q3 2014 Results - Earnings Call Webcast
Oct. 30, 2014 | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q3 2014 Results - Earnings Call Transcript
Oct. 30, 2014 | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Q2 2014 Results - Earnings Call Transcript
Aug. 7, 2014 | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham Hosts 2014 Annual Meeting of Stockholders Conference
May 22, 2014 | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Bank of America Merrill Lynch 2014 Health Care Conferenc
May 13, 2014 | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Q1 2014 Results - Earnings Call Transcript
May 6, 2014 | Source: Seeking Alpha

Q1 2014 Theravance Inc Earnings Conference Call (THRX) Q1 2014 Results - Earnings Call Webcast
May 6, 2014 | Source: Seeking Alpha

Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia
May 1, 2014 | Source: Seeking Alpha

Theravance's CEO Presents at Barclays Global Healthcare Conference (Transcript)
March 11, 2014 | Source: Seeking Alpha

Q4 2013 Theravance Inc Earnings Conference call (Webcast)
Feb. 7, 2014 | Source: Seeking Alpha

Theravance's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 7, 2014 | Source: Seeking Alpha

Theravance's Management Presents at 32nd Annual JPMorgan Healthcare Conference (Transcript)
Jan. 16, 2014 | Source: Seeking Alpha

Theravance's CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Source: Seeking Alpha

Theravance Inc's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 24, 2013 | Source: Seeking Alpha

Theravance's CEO Reviews Phase 2b Study 0091 with its LAMA Candidate TD-4208 Results - Transcript
Sept. 5, 2013 | Source: Seeking Alpha

Theravance Inc (THRX) CEO Discusses Q2 2013 Results - Earnings Call Transcript
July 25, 2013 | Source: Seeking Alpha

Theravance's Management Presents at Goldman Sachs Healthcare Conference (Transcript)
June 13, 2013 | Source: Seeking Alpha

Theravance's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
May 15, 2013 | Source: Seeking Alpha

Theravance and Elan Enter Into a 1 Billion Dollar Royalty Participation Agreement (Transcript)
May 13, 2013 | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Source: Seeking Alpha

Theravance's CEO Hosts 2013 Annual Meeting of Stockholders Conference (Transcript)
April 24, 2013 | Source: Seeking Alpha

Theravance Management Presents at Barclays 2013 Global Healthcare Conference (Transcript)
March 14, 2013 | Source: Seeking Alpha

Theravance's CEO Presents at 2013 Citi Global Healthcare Conference (Transcript)
Feb. 27, 2013 | Source: Seeking Alpha

Theravance's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Feb. 13, 2013 | Source: Seeking Alpha

Theravance's CEO Presents at J.P. Morgan Global Healthcare Conference (Transcript)
Jan. 9, 2013 | Source: Seeking Alpha

Theravance's Management Presents at Credit Suisse 2012 Healthcare Conference (Transcript)
Nov. 14, 2012 | Source: Seeking Alpha

Theravance's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Oct. 30, 2012 | Source: Seeking Alpha

Theravance's Management Present at Morgan Stanley Global Healthcare Conference (Transcript)
Sept. 12, 2012 | Source: Seeking Alpha

Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript
July 31, 2012 | Source: Seeking Alpha

Theravance's CEO Announces Positive Topline Results From TD-1211 Phase 2b Study 0084 for the Treatm
July 12, 2012 | Source: Seeking Alpha

Theravance's CEO Discusses LAMA/LABA Phase 3a Results Conference Call (Transcript)
July 2, 2012 | Source: Seeking Alpha

Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript
Oct. 21, 2010 | Source: Seeking Alpha

Theravance Inc Q2 2010 Earnings Call Transcript
July 22, 2010 | Source: Seeking Alpha

Theravance Inc. Q1 2010 Earnings Call Transcript
April 21, 2010 | Source: Seeking Alpha

Theravance, Inc. Q3 2009 Earnings Call Transcript
Oct. 27, 2009 | Source: Seeking Alpha

Theravance, Inc. Q4 2008 Earnings Call Transcript
Feb. 12, 2009 | Source: Seeking Alpha

Theravance, Inc. Q3 2008 Earnings Call Transcript
Oct. 29, 2008 | Source: Seeking Alpha

Theravance, Inc. Q2 2008 Earnings Call Transcript
Aug. 11, 2008 | Source: Seeking Alpha

Recent filings

Major owner of Theravance was just granted 30,000 options - June 13, 2022

Theravance's Chairman was just granted 45,000 options - June 13, 2022

James B. Tananbaum just provided an update on activist position in Theravance - June 13, 2022

Submission of Matters to a Vote of Security - June 13, 2022

Major owner of Theravance just declared owning 4,294,621 shares of Theravance - June 13, 2022

Theravance director was just granted 30,000 options - June 13, 2022

Theravance director was just granted 60,000 options - May 18, 2022

Theravance: Theseus Pharmaceuticals Appoints Donald Hayden To Board Of Directors - May 18, 2022

Theravance director just declared ownership of no shares of Theravance - May 18, 2022

Theravance: Theseus Pharmaceuticals Announces Business Highlights And Reports First Quarter 2022 Financial Results - May 12, 2022

Theravance Just Filed Its Quarterly Report: 12. Net Loss Per Sha... - May 12, 2022

Other definitive proxy statements - April 25, 2022

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 25, 2022

Theravance Just Filed Its Annual Report: Net Loss Per ShareTh... - March 10, 2022

Theravance: Theseus Pharmaceuticals Announces Business Highlights And Reports Fourth Quarter And Full Year 2021 Financial Results - March 10, 2022

Theravance's Chief Medical Officer was just granted 150,000 options - Feb. 23, 2022

Theravance's Chief Technical Officer was just granted 130,000 options - Feb. 23, 2022

Theravance's Chief Financial Officer was just granted 150,000 options - Feb. 23, 2022

Theravance's See Remarks was just granted 180,000 options - Feb. 23, 2022

Theravance's Chief Scientific Officer was just granted 130,000 options - Feb. 23, 2022

Theravance's President and CEO was just granted 450,000 options - Feb. 23, 2022

Statement of acquisition of beneficial ownership by individuals - Feb. 9, 2022

Major owner of Theravance just picked up 158,417 shares - Jan. 21, 2022

Major owner of Theravance just picked up 158,417 shares - Jan. 21, 2022

Major owner of Theravance just picked up 44,717 shares - Jan. 13, 2022

Major owner of Theravance just picked up 44,717 shares - Jan. 13, 2022

Theravance: Theseus Pharmaceuticals Announces First Patient Treated With The-630 In Phase 1/2 Study In Patients - Jan. 10, 2022

Theravance's Chief Financial Officer just picked up 1,971 shares - Dec. 22, 2021

Theravance's President and CEO just picked up 2,600 shares - Dec. 22, 2021

OrbiMed Genesis GP LLC just provided an update on activist position in Theravance - Nov. 18, 2021

Theravance Just Filed Its Quarterly Report: 13. Net Loss Per Sha... - Nov. 15, 2021

Theravance: Theseus Pharmaceuticals Announces Business And Program Highlights And Reports Third Quarter 2021 Financial Results - Nov. 15, 2021

Statement of acquisition of beneficial ownership by individuals - Nov. 10, 2021

On October  - Oct. 27, 2021

OrbiMed Genesis GP LLC just provided an update on activist position in Theravance - Oct. 19, 2021

James just provided an update on activist position in Theravance - Oct. 18, 2021

Major owner of Theravance just picked up 1,615,427 shares - Oct. 15, 2021

Major owner of Theravance just declared 0 ownership of the company. - Oct. 15, 2021

Theravance's See Remarks just picked up 625 shares - Oct. 14, 2021

Theravance insider just picked up 711,479 shares - Oct. 14, 2021

Major owner of Theravance just picked up 16,838,668 shares - Oct. 14, 2021

Major owner of Theravance just picked up 16,838,668 shares - Oct. 14, 2021

Major owner of Theravance just picked up 686,649 shares - Oct. 14, 2021

Securities to be offered to employees in employee benefit plans - Oct. 8, 2021

Theravance's Chief Accounting Officer just disposed of 1,129 shares - Aug. 24, 2021

Theravance's Chief Accounting Officer just disposed of 2,433 shares - Aug. 23, 2021

Theravance Just Filed Its Quarterly Report: 2. Net Income Per Sh... - July 29, 2021

Theravance: Innoviva Reports Second Quarter 2021 Financial Results - July 28, 2021

Major owner of Theravance just picked up 6,268,975 shares - June 11, 2021

Statement of acquisition of beneficial ownership by individuals - June 7, 2021

Current report, item 1.01 - May 26, 2021

General statement of acquisition of beneficial ownership - May 25, 2021

Statement of changes in beneficial ownership of securities - May 25, 2021

Theravance director just picked up 20,000 shares - May 25, 2021

General statement of acquisition of beneficial ownership - May 25, 2021

Theravance's Chief Accounting Officer just disposed of 759 shares - May 24, 2021

Statement of changes in beneficial ownership of securities - May 24, 2021

Current report, items 1.01, 8.01, and 9.01 - May 20, 2021

Submission of Matters to a Vote of Security - May 20, 2021

Statement of changes in beneficial ownership of securities - May 20, 2021

Major owner of Theravance just picked up 3,731,025 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - May 5, 2021

General statement of acquisition of beneficial ownership - May 3, 2021

General statement of acquisition of beneficial ownership - April 5, 2021

Other definitive proxy statements - April 2, 2021

Theravance director just picked up 1,612 shares - March 30, 2021

Theravance's Chief Accounting Officer just picked up 10,305 shares - March 30, 2021

Theravance director was just granted 10,748 restricted shares - March 24, 2021

Major owner of Theravance just picked up 4,285,935 shares - March 17, 2021

Innoviva Strategic Opportunities LLC just provided an update on activist position in Theravance - March 17, 2021

Theravance director just declared 0 ownership of the company. - March 16, 2021

Departure of Directors or Principal - March 10, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - Feb. 25, 2021

Theravance's Chief Accounting Officer just disposed of 2,108 shares - Feb. 22, 2021

Renaissance Technologies LLC just provided an update on share ownership of Theravance - Feb. 11, 2021

The Vanguard Group just provided an update on share ownership of Theravance - Feb. 10, 2021

Theravance: Innoviva Reports Fourth Quarter 2020 Financial Results - Feb. 3, 2021

Major owner of Theravance just picked up 1,867,912 shares - Jan. 28, 2021

BlackRock, Inc. just provided an update on share ownership of Theravance - Jan. 27, 2021

Innoviva Strategic Opportunities LLC just provided an update on activist position in Theravance - Jan. 27, 2021

Entry into a Material Definitive Agreement - Dec. 14, 2020

Sarissa Capital Master Fund II LP just provided an update on activist position in Theravance - Dec. 14, 2020

Sorry, no schedule available for this company

 


Feedback